Entering text into the input field will update the search result below

Exact Sciences Q1 revenue up 79%; Cologuard volume up 79%

Apr. 30, 2019 4:36 PM ETExact Sciences Corporation (EXAS) StockBy: Douglas W. House, SA News Editor4 Comments
  • Exact Sciences (NASDAQ:EXAS) Q1 results ($M): Revenue: 162.0 (+79.4%).
  • Net loss: (83.1) (-110.9%); loss/share: (0.66) (-100.0%).
  • Cologuard test volume: 334K (+79%); average revenue/test: $483 (-0.04%); average cost/test: $128 (+3.2%).
  • 2019 guidance: Revenue: $725M - 740M from $710M - 730M.
  • Shares are down 3% after hours.
  • Previously: EXACT Sciences beats by $0.07, beats on revenue (April 30)

Recommended For You

About EXAS Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
EXAS--
Exact Sciences Corporation